NeuPath Health Inc.
NPTH.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.35% | 7.09% | 8.46% | 7.25% | 6.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.35% | 7.09% | 8.46% | 7.25% | 6.14% |
| Cost of Revenue | 11.27% | 6.56% | 7.89% | 6.12% | 4.44% |
| Gross Profit | 11.65% | 9.39% | 10.96% | 12.33% | 14.06% |
| SG&A Expenses | 8.73% | 5.96% | 8.04% | 8.53% | 6.22% |
| Depreciation & Amortization | -9.34% | -12.31% | -13.05% | -4.24% | -2.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.16% | 5.75% | 7.08% | 6.05% | 4.39% |
| Operating Income | 93.05% | 146.74% | 212.69% | 247.61% | 801.24% |
| Income Before Tax | -144.03% | -210.58% | -536.96% | 62.97% | 108.36% |
| Income Tax Expenses | 45.56% | 10.31% | -15.35% | -44.42% | 20.12% |
| Earnings from Continuing Operations | -8,146.51% | -45.33% | -159.29% | 59.75% | 100.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -283.90% | -1,741.09% | -383.20% | -239.53% | -147.52% |
| Net Income | -952.21% | -153.52% | -612.70% | 44.94% | 97.59% |
| EBIT | 93.05% | 146.74% | 212.69% | 247.61% | 801.24% |
| EBITDA | 26.50% | 26.92% | 27.71% | 26.46% | 49.80% |
| EPS Basic | -910.00% | -152.63% | -533.33% | 51.93% | 97.77% |
| Normalized Basic EPS | 566.67% | 152.00% | 121.43% | 63.33% | 86.36% |
| EPS Diluted | -314.71% | -119.35% | -833.33% | 32.62% | 92.41% |
| Normalized Diluted EPS | 544.44% | 152.00% | 121.43% | 63.33% | 85.48% |
| Average Basic Shares Outstanding | 0.19% | 0.36% | 2.25% | 5.05% | 8.07% |
| Average Diluted Shares Outstanding | 1.04% | 0.70% | 2.32% | 5.11% | 6.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |